Is PKAN fatal?
PKAN is an incredibly rare, and always fatal, disease that creates build up of iron in the brain, causing developmental difficulties. On average, children diagnosed with PKAN do not live past the age of 11.
Is there a cure for PKAN?
Although there is currently no established therapy for PKAN, various drugs are used to alleviate or lessen its symptoms. Baclofen, a gamma-aminobutyric acid (GABA) receptor agonist, is one of the ‘mainstay drugs’ used to treat dystonia in patients with PKAN4.
What causes PKAN disease?
PKAN is an autosomal recessive condition caused by mutations in the PANK2 gene, located on chromosome 20. This gene encodes the enzyme pantothenate kinase, and mutations in the gene lead to an inborn error of vitamin B5 (pantothenate) metabolism. Vitamin B5 is required for the production of coenzyme A in cells.
What is Neuroferritinopathy?
Neuroferritinopathy is a disorder in which iron gradually accumulates in the brain. Certain brain regions that help control movement (basal ganglia) are particularly affected. People with neuroferritinopathy have progressive problems with movement that begin at about age 40.
What is NBIA?
Neurodegeneration with brain iron accumulation (NBIA) are a group of very rare nervous system disorders. They are passed down through families (inherited). NBIA involves movement problems, dementia, and other nervous system symptoms.
What is Aceruloplasminemia?
Aceruloplasminemia is a rare genetic disorder characterized by the abnormal accumulation of iron in the brain and various internal organs. Affected individuals develop neurological symptoms including cognitive impairment and movement disorders.
What is BPAN?
Beta-propeller protein-associated neurodegeneration (BPAN) is a disorder that damages the nervous system and is progressive, which means that it gradually gets worse. Affected individuals develop a buildup of iron in the brain that can be seen with medical imaging.
What is INAD disease?
Infantile Neuroaxonal Dystrophy (INAD) is a rare neurodegenerative disease that often cuts short the life span of a child to 10 years. With a typical onset at 6 months of age, INAD is characterized by regression of acquired motor skills, delayed motor coordination and eventual loss of voluntary muscle control.
What is Atransferrinemia?
Atransferrinemia is an extremely rare genetic disorder characterized by low levels of healthy, functional red cells in the blood (hypochromic, microcytic anemia) and by the accumulation of excess iron in the body (hemosiderosis).
How long do people with BPAN live?
The life span of people with BPAN syndrome varies. With proper management of their symptoms and symptoms, people with this disease can live up to middle age. Death may be due to mental retardation or motor problems, such as damage from falling or difficulty swallowing (dysphagia).
How is BPAN diagnosed?
Diagnosis of BPAN is confirmed through genetic testing of the WDR45 gene to find a gene change. Genetic testing begins with sequence analysis, and if no gene changes are found, then it continues on to deletion/duplication analysis.
What are the effects of mutations in the PANK2 gene?
The presence of mutation in the PANK2 gene is associated with younger age at onset and a higher frequency of dystonia, dysarthria, intellectual impairment, and gait disturbance. Parkinsonism is seen predominantly in adult-onset patients
Can a mutation in PANK2 cause Hallervorden-Spatz syndrome?
PANK2 gene mutations can cause Hallervorden-Spatz syndrome in Chinese patients. a novel missense mutation (P354L) in exon 4 of the PANK2 gene in an adolescent with classic pantothenate kinase-associated neurodegeneration was identified Focal hand dystonia showed atypical phenotype of PANK2 gene mutations.
What are the effects of PANK2 overexpression in mice?
Results show that overexpression of PANK2 results in substantial elevated level of Co-A in skeletal muscle in transgenic mice which displays reduced skeletal muscle mass and significantly impaired exercise tolerance and grip strength. Homozygous PANK2 mutations in 22 PKAN patients from 13 Turkish families.
How is PANK2 predicted to localize to mitochondria?
PANK2 is predicted to localize to mitochondria, with a 29 amino acid mitochondrial targeting sequence identified. Unique biochemical features of the PanK2 isoforms suggest that catalytic defects may not be the sole cause for the neurodegenerative phenotype.